The findings from this study support the notion that primary care clinics are an appropriate setting for assessing social and behavioral determinants of health.
FDA’s Nutrition Initiatives - U.S. Food and Drug Administration
Jun 13, 2025 · FDA is prioritizing its nutrition initiatives to ensure people in the United States have greater access to healthier foods and nutrition information we can all use to make healthier choices …
Healthy People: A National Initiative | FDA
The Healthy People initiative is a collaborative health promotion and disease prevention effort with a vision towards a healthier nation.
Vulnerability Assessments | FDA
FDA conducts vulnerability assessments (VA) on food systems to identify, quantify and prioritize (or rank) the vulnerabilities in a system.
National Security Memorandum-16 (NSM-16) recognizes the vulnerability of complex FA systems to terrorist attacks, major disasters, and other emergencies with the potential for catastrophic health ...
Integrated Food Safety System (IFSS) | FDA
Dec 16, 2024 · Leverage the resources, experience, subject matter expertise, and efforts among partners to create an integrated global food safety network that will achieve the best public health …
These voluntary guidelines provide a list of safety and security measures these entities should consider to strengthen their food safety and food security plans.
Strengthening the Security and Resilience of U.S. Food and Agriculture ...
Jul 13, 2023 · The review includes proposed short-term, mid-term and long-term actions for improved coordination and integration within the Food and Agriculture Sector in strategic planning, information …
Security and Resilience of United States Food and Agriculture
The National Security Memorandum on Strengthening the Security and Resilience of United States Food and Agriculture (NSM-16) is a plan for federal government agencies, along with SLTT governments ...
Office of Economics and Analysis | FDA
Jul 17, 2023 · The Office of Economics and Analysis (OEA) provides public health, economic, and strategic analysis and evaluation to inform FDA’s policy and rulemaking decisions.